Zydus Pharmaceuticals

Rediff.com » News » Zydus Pharmaceuticals

News for Zydus Pharmaceuticals

News
Business

How companies show electoral donations in annual reports

A reading of the reports suggests that there is no standard practice for reporting political contributions and it is left to the company's discretion to report them as they find fit. Illustration:......

8 vaccines, 4 treatments in India's COVID-19 arsenal

The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments......

Govt developing multi-variant Covid-19 vaccine

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus,......

Covid vaccines for children likely by Sept: AIIMS chief

Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences director Randeep Guleria......

Sputnik V vaccine to be available in India from next week: Govt

India is expecting 156 million doses of the vaccine from August to September, reports Ruchika Chitravanshi. Photograph: Kind courtesy Russian Direct Investment Fund on Facebook Sputnik V, the......

Lower input costs may aid pharma firms' Q2 margins

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and......

Pharma cos okay with QR codes to combat counterfeit drugs

As the Drugs Controller General of India (DCGI) is set to crack down on companies to ensure compliance with printing QR codes on top-selling brands to curb counterfeiting, top pharma companies say......

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. Illustration: Uttam......

India's pharma industry likely to take 5-6% price hikes this year

Notwithstanding the fact that the country’s pharmaceutical (pharma) pricing regulator has allowed a 12 per cent price increase for medicines listed under the National List of Essential......

US drug shortage, stable pricing set to boost pharma revenues

An acute drug shortage in the US and stable pricing along with product launches are likely to boost revenues of India’s pharmaceutical companies during the first quarter of this financial......

Rediff News

Zydus Pharmaceuticals

News for Zydus Pharmaceuticals

How companies show electoral donations in annual reports

8 vaccines, 4 treatments in India's COVID-19 arsenal

Govt developing multi-variant Covid-19 vaccine

Covid vaccines for children likely by Sept: AIIMS chief

Sputnik V vaccine to be available in India from next week: Govt

Lower input costs may aid pharma firms' Q2 margins

Pharma cos okay with QR codes to combat counterfeit drugs

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

India's pharma industry likely to take 5-6% price hikes this year

US drug shortage, stable pricing set to boost pharma revenues

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS